Chemed Corporation (CHE) is a publicly traded Healthcare sector company. As of October 27, 2026, CHE trades at $503.31 with a market cap of $6.70B and a P/E ratio of 25.55. CHE moved -2.16% today. Year to date, CHE is +21.03%; over the trailing twelve months it is +17.47%. Its 52-week range spans $365.21 to $623.61. Analyst consensus is buy with an average price target of $584.50. Rallies surfaces CHE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Chemed Corporation (CHE) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CHE moved -2.16% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $503.31 |
| Market Cap | $6.70B |
| P/E Ratio | 25.55 |
| EPS | $19.90 |
| Dividend Yield | 0.70% |
| 52-Week High | $623.61 |
| 52-Week Low | $365.21 |
| Volume | 93.61K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.60B |
| Net Income | $274.99M |
| Gross Margin | 33.11% |
4 analysts cover CHE: 0 strong buy, 2 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $584.50.